The Rapidly Evolving Treatment Landscape in Newly Diagnosed Multiple Myeloma: Current Status and Future Directions
Over the past two decades, significant progress has been made in the management of multiple myeloma (MM), leading to the development of novel therapeutic approaches and treatment regimens to improve patient outcomes. In patients with newly diagnosed MM (NDMM), the introduction of anti-CD38 monoclona...
Saved in:
Main Authors: | Yuxin Liu, Clifton Mo, Monique Hartley-Brown, Shonali Midha, Adam S. Sperling, Giada Bianchi, Omar Nadeem, Betsy O’Donnell, Jacob Laubach, Paul G. Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
THE HEALTHBOOK COMPANY LTD.
2024-10-01
|
Series: | healthbook TIMES. Oncology Hematology |
Online Access: | https://doi.org/10.36000/HBT.OH.2024.21.159 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
by: Charlotte Pawlyn, et al.
Published: (2024-08-01) -
Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma
by: Benjamin A. Derman, et al.
Published: (2018-01-01) -
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
by: Luciano J. Costa, et al.
Published: (2025-02-01) -
Expression profile of Bcl‐2 family proteins in newly diagnosed multiple myeloma patients
by: Cristina De Ramón, et al.
Published: (2024-12-01) -
A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
by: Wang M, et al.
Published: (2025-02-01)